40
Participants
Start Date
October 27, 2022
Primary Completion Date
January 1, 2023
Study Completion Date
January 4, 2023
Auricular transcutaneous vagus nerve stimulation
Transcutaneous vagus nerve stimulation (taVNS) was performed with an FDA-approved Vagustim stimulation device and an electrode-shaped earpiece. In the participants included in the study and randomized to two groups, i) left ear taVNS was applied to the first group and ii) double-ear taVNS was applied to the second group.
Iğdır State Hospital, Iğdır
Bahçeşehir University
OTHER